Low‐Cost, High‐Pressure‐Synthesized Oxygen‐Entrapping Materials to Improve Treatment of Solid Tumors
Advanced Science · 2023
DOI: 10.1002/advs.202205995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Jianling Bi und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Iowa, 200 Hawkins Drive, Iowa City, IA, 52242, USA. Hauptthemen laut MEDLINE: Neoplasms, Hyperbaric Oxygenation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Tumor hypoxia drives resistance to many cancer therapies, including radiotherapy and chemotherapy. Methods that increase tumor oxygen pressures, such as hyperbaric oxygen therapy and microbubble infusion, are utilized to improve the responses to current standard‐of‐care therapies. However, key obstacles remain, in particular delivery of oxygen at the appropriate dose and with optimal pharmacokinetics. Toward overcoming these hurdles, gas‐entrapping materials (GeMs) that are capable of tunable oxygen release are formulated. It is shown that injection or implantation of these materials into tumors can mitigate tumor hypoxia by delivering oxygen locally and that these GeMs enhance responsiveness to radiation and chemotherapy in multiple tumor types. This paper also demonstrates, by comparing an oxygen (O 2 )‐GeM to a sham GeM, that the former generates an antitumorigenic and immunogenic tumor microenvironment in malignant peripheral nerve sheath tumors. Collectively the results indicate that the use of O 2 ‐GeMs is promising as an adjunctive strategy for the treatment of solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Iowa, 200 Hawkins Drive, Iowa City, IA, 52242, USA.
- Department of Biomedical Engineering, University of Iowa, 200 Hawkins Drive, Iowa City, IA, 52242, USA.
- Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, 52242, USA.
- Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 3 Blackfan Circle, Boston, MA, 02215, USA.
- Division of Gastroenterology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St., Boston, MA, 02115, USA.
- David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main St Building 76, Cambridge, MA, 02142, USA.
ORCID-Profile: Wade R Gutierrez, James D Byrne
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- Holden Comprehensive Cancer Center, University of Iowa
Zitieren
APA
Bi, J., Witt, E., Voltarelli, V. A., Feig, V. R., Venkatachalam, V., Boyce, H., McGovern, M., Gutierrez, W. R., Rytlewski, J. D., Bowman, K. R., Rhodes, A. C., Cook, A. N., Muller, B. N., Smith, M. G., Ramos, A. R., Panchal, H., Dodd, R. D., Henry, M. D., Mailloux, A., …, & Byrne, J. D. (2023). Low‐Cost, High‐Pressure‐Synthesized Oxygen‐Entrapping Materials to Improve Treatment of Solid Tumors. Advanced Science. https://doi.org/10.1002/advs.202205995
Vancouver
Bi J, Witt E, Voltarelli VA, Feig VR, Venkatachalam V, Boyce H, et al. Low‐Cost, High‐Pressure‐Synthesized Oxygen‐Entrapping Materials to Improve Treatment of Solid Tumors. Advanced Science. 2023. doi:10.1002/advs.202205995
BibTeX
@article{Bi2023,
author = {Bi, Jianling and Witt, Emily and Voltarelli, Vanessa A and Feig, Vivian R and Venkatachalam, Veena and Boyce, Hannah and McGovern, Megan and Gutierrez, Wade R and Rytlewski, Jeffrey D and Bowman, Kate R and Rhodes, Ashley C and Cook, Austin N and Muller, Benjamin N and Smith, Matthew G and Ramos, Alexis Rebecca and Panchal, Heena and Dodd, Rebecca D and Henry, Michael D and Mailloux, Adam and Traverso, Giovanni and Otterbein, Leo E and Byrne, James D},
title = {Low‐Cost, High‐Pressure‐Synthesized Oxygen‐Entrapping Materials to Improve Treatment of Solid Tumors},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202205995}
}
EUVIMED